Janet Rose Rea
Directeur des opérations chez Ave Maria Biotechnology LLC
Profil
Janet Rose Rea is currently the Chief Operating Officer at Ave Maria Biotechnology LLC.
Previously, she worked as the VP-Regulatory Affairs, Quality & Clinical Affairs at Atossa Therapeutics, Inc. from 2015 to 2020.
She also served as an Assistant Clinical Professor at the University of Washington.
Ms. Rea completed her undergraduate and graduate degrees at the University of Washington.
Postes actifs de Janet Rose Rea
| Sociétés | Poste | Début |
|---|---|---|
Ave Maria Biotechnology LLC
 Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Directeur des opérations | 08/07/2020 |
Anciens postes connus de Janet Rose Rea
| Sociétés | Poste | Fin |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Conseiller Juridique Général | 01/07/2020 |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Formation de Janet Rose Rea
| University of Washington | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ave Maria Biotechnology LLC
Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Commercial Services |
